# ClinicalTrials.gov record NCT01444898

> PeptideScanner retained ClinicalTrials.gov record NCT01444898 at 2026-07-30T21:36:16.906Z. Its registry update date was 2016-09-29, and PeptideScanner's reviewed identity mapping was exenatide.

- Evidence object: `story:clinicaltrials-gov-nct01444898-exenatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2016-09-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01444898-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01444898-exenatide-v1.json
- Content SHA-256: `bfbadf3370d8e325cf1c3182dea7b46fe53f834bd6ea0cf6a4291b58574bdf33`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01444898 ([`ctg-observation-nct01444898-2016-09-29-3e252c58b626`](#source-ctg-observation-nct01444898-2016-09-29-3e252c58b626))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01444898 at 2026-07-30T21:36:16.906Z. Its registry update date was 2016-09-29, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct01444898-2016-09-29-3e252c58b626`](#source-ctg-observation-nct01444898-2016-09-29-3e252c58b626))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01444898 at 2026-07-30T21:36:16.906Z. Its registry update date was 2016-09-29, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct01444898-2016-09-29-3e252c58b626`](#source-ctg-observation-nct01444898-2016-09-29-3e252c58b626))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01444898-2016-09-29-3e252c58b626`](#source-ctg-observation-nct01444898-2016-09-29-3e252c58b626))

## Sources

<a id="source-ctg-observation-nct01444898-2016-09-29-3e252c58b626"></a>
- **ClinicalTrials.gov record NCT01444898 · retained source version 2016-09-29:3e252c58b62668a694bad3f1447534c3fe6d5ec3ef315b6f6499ccf93ebe636f** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01444898) (`ctg-observation-nct01444898-2016-09-29-3e252c58b626`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01444898." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01444898-exenatide-v1.json SHA-256: bfbadf3370d8e325cf1c3182dea7b46fe53f834bd6ea0cf6a4291b58574bdf33.